Latest Biotech News

Researchers led by Nobel Laureate David Baker have harnessed artificial intelligence to design protein binders for intrinsically disordered regions (IDRs), previously considered undruggable...

Emerging analyses highlight the potential of quantum computing to address complex challenges in biopharma, including molecular modeling and drug discovery processes difficult for classical...

Data from the first half of 2025 indicate an increase in seed and Series A financing rounds within biotech, with $4.7 billion raised. However, the funding landscape is marked by concentration,...

The Organizational Unit Core Facilities at the Medical University of Vienna received €2.5 million from the Austrian Research Promotion Agency to enhance multiomics-based biomarker discovery and...

GenesisM, a joint venture between Bain Capital Real Estate and Botanic Properties, has initiated construction on a 154,000-square-foot Class A biomanufacturing facility in Bedford, Massachusetts....

Sarepta Therapeutics is facing escalating safety concerns as a third patient has died after receiving one of its gene therapies. The latest fatality involved a 51-year-old participant in a...

Scipher Medicine is evolving its strategy to expand beyond rheumatoid arthritis diagnostics toward broader personalized medicine using clinicogenomic datasets. Under new leadership, Scipher now...

The FDA Psychopharmacologic Drugs Advisory Committee voted 10-1 against the approval of Otsuka Pharmaceutical's combination therapy of Rexulti and Zoloft for PTSD treatment. Committee members...

Bristol Myers Squibb announced failure of Reblozyl to meet the primary endpoint in the Phase III INDEPENDENCE trial for anemia associated with myelofibrosis, showing no significant reduction in...

GenesisM, a joint venture between Bain Capital Real Estate and Botanic Properties, has commenced construction of a 154,000-square-foot Class A biomanufacturing facility in Bedford, Massachusetts....

Thermo Fisher Scientific has agreed to acquire Sanofi’s sterile fill-finish and packaging facility in Ridgefield, New Jersey, enhancing Thermo Fisher’s U.S. manufacturing footprint. The site’s...

Researchers from David Baker’s laboratory have developed AI techniques to design protein binders targeting intrinsically disordered regions (IDRs) of proteins, long considered undruggable due to...

The Medical University of Vienna’s Organizational Unit Core Facilities received €2.5 million from the Austrian Research Promotion Agency to advance multiomics-driven biomarker discovery and...

Capital flows into early-stage biotech startups have increased in the first half of 2025, with seed and Series A rounds rising to a total of $4.7 billion. However, fewer companies contributed to...

A University of Pennsylvania team has demonstrated that modifying the ionizable lipid component of lipid nanoparticles (LNPs) by adding phenol groups can both reduce inflammatory side effects and...

Sarepta Therapeutics is facing intensified regulatory and commercial challenges following the confirmation of a third patient death related to its gene therapy products. The newest fatality...

Recent FDA advisory committee meetings have dealt significant blows to GSK and Otsuka’s drug approval plans. GSK’s attempt to reintroduce its multiple myeloma antibody-drug conjugate Blenrep in...

Scipher Medicine, recently under new leadership, is transitioning beyond its commercial molecular assay for rheumatoid arthritis to broader personalized medicine applications across non-oncology...

The FDA’s June approvals included 22 drugs, equaling the March total and pushing 2025 into the third-highest year on record for new drug approvals at midyear. Notable approvals include Gilead’s...

The first half of 2025 witnessed a rise in seed and Series A funding in the biotech space, although the number of companies participating declined, reflecting concentrated investment. A prominent...